From 2 to 3 December
The International Viral Hepatitis Elimination Meeting (IVHEM) will take place as a hybrid meeting on 2-3 December 2022. Convened by Academic Medical Education, Virology Education, and the Coalition for Global Hepatitis Elimination, IVHEM is a global forum for the exchange of practical experiences for translating diagnostic and therapy advances of viral hepatitis into broad applications that accelerate progress towards the elimination of viral hepatitis as a public health threat by 2030.
Hepatitis B and C affect more than 320 million people globally and can lead to liver disease and mortality from liver failure and hepatocellular carcinoma. More than 248 million people (3.8% of the world’s population) live with hepatitis B virus (HBV), and over 700,000 deaths are attributable annually. An estimated 80 million people (globally, 1.1%) live with the hepatitis C virus (HCV), resulting in nearly 500,000 deaths annually.
Key issues to be addressed are how to translate research outcomes into public health policy and practice to meet the 2030 elimination targets. During this two-day meeting, experts in viral hepatitis from around the globe will examine current evidence on how to implement programs that improve the prevention of viral hepatitis and increase the number of people accessing testing and treatment.
The program includes practical examples of innovative intervention studies, country elimination programs, and novel funding mechanisms for testing and treatment.
Further details are available here.